Navigation Links
Everist Genomics Announces Worldwide Availability of OncoDefender™-CRC
Date:3/28/2011

e US (approximately 22,000 Stage I, and 46,000 Stage II), 90% of those with Stage I and 70% of those with Stage II likely will be cured by surgery alone.  The remaining 10% of those with Stage I (about 2,200) and 30% with Stage II (about 14,000) will ultimately recur and die of advanced colorectal cancer, consequent to undetected tumor remaining following definitive surgery. (4)Many of these latter patients may have been cured or had their lives prolonged had they been more accurately identified as being at 'high-risk' for tumor recurrence and received post-surgical resection adjuvant therapy.  Identifying those patients at high-risk for colorectal cancer recurrence can reduce mortality, morbidity and cost of care.  

Independent studies(5) have demonstrated a significant improvement in overall survival rates for high-risk Stage I and Stage II colorectal cancer patients receiving adjuvant therapy within 60 days following surgical resection of their tumor.

About Everist Genomics

Everist Genomics is a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence and proprietary point-of-care equipment for the evaluation and management of cardiovascular disease. Using its patented Evolver™ technology platform, Everist Genomics is successfully developing and commercializing entirely new classes of patent-protected molecular biomarkers and sensor technologies which employ proprietary equipment, devices and software to help physicians make individualized treatment and drug prescribing decisions.  The privately owned company was founded in 2002 and is located in Ann Arbor, Michigan.  For more information, please visit www.everistgenomics.com

(1) Zosia Chustecka. More Genetic Tests to Predict Recurrence in Stage II Colon. Medscape Today. January 20, 2011. Free article can be found at:

SOURCE Everist Genomics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Genetics Squared Changes Name To Everist Genomics
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
5. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
6. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
7. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
8. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
9. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
10. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
11. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Intelomed is pleased to announce that ... as the Vice President of Clinical Affairs. With over ... device industry, Kay,s experience in taking medical technology and ... to global expansion, is a valuable addition to the ... on our team, and I am confident her focused ...
(Date:8/26/2014)... Research and Markets has announced ... Report 2014 " report to their offering. ... is a professional and in-depth study on the current ... The report provides a basic overview of the industry ... glucose meter market analysis is provided for both the ...
(Date:8/26/2014)... DUBLIN , Aug. 26, 2014 ... "Global Intranasal Drug Delivery Market 2014-2018" report ... is a medical device used for the administration of ... nose and paranasal sinus such as allergic and non-allergic ... an ideal administrative route for needle-free vaccination and systematic ...
Breaking Medicine Technology:Mary Kay Deck joins Intelomed as Vice President of Clinical Affairs 2Global Glucose Meter Industry Report 2014 2Global Glucose Meter Industry Report 2014 3Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 2Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 3
(Date:8/27/2014)... participation in the largest ongoing observational study of U.S. ... of the larger patient base, according to a study ... The study authors call into question the general applicability ... the use of broader enrollment criteria and existing patient ... clinical trials can be tremendously expensive and a huge ...
(Date:8/27/2014)... scientists are trying to prevent the onset of ... at Virginia Commonwealth University Massey Cancer Center are ... the process to culminate in cell death rather ... p62 protein, which is often referred to as ... disposing unwanted cellular proteins during autophagy. Results from ...
(Date:8/27/2014)... in Disability (CLD) has received a two-year, $600,000 ... of the Health Resources and Services Administration to ... aimed at improving services for children and youth ... this project, CLD worked with an Autism Advisory ... The resulting plan addresses priorities of increased awareness ...
(Date:8/27/2014)... 8/27/14)Dartmouth cancer researchers developed and tested an advanced ... interactions that contribute to disease as published yesterday ... The approach fills a gap in current analyses. ... interactions among genetic and environmental factors. When many ... versus those that reflect chance combinations among affected ...
(Date:8/27/2014)... CA (PRWEB) August 27, 2014 Jaha was ... do this, Jaha invested in creating the industry’s most affordable ... adding functions that no other apps possess. Jaha ... tracker that differentiates in three simple steps: locate, challenge and ... on Tuesday, Aug 26, 2014 to garner support and to ...
Breaking Medicine News(10 mins):Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2Health News:Promising new cancer therapy uses molecular 'Trash Man' to exploit a common cancer defense 2Health News:Dartmouth isolates environmental influences in genome-wide association studies 2Health News:Jaha, Inc. The Most Affordable Fitness Band in the Market Released on Kickstarter 2
... National Kidney FoundationMOUNTAIN VIEW, Calif., April 20 Satellite ... of kidney dialysis services and a major sponsor of ... will be honored by the National Kidney Foundation at ... 23 at Yoshi,s Jazz Club in San Francisco. Linda ...
... 20 The managing director of Publication CONNEXION, ... speak at the 45th Annual Drug Information Association ... be present a talk entitled "Effective Publication Practices" ... is a pharmaceutical industry five-day summit uniting professionals ...
... San Diego just moved closer to unlocking the ... mode" to "specialization mode." This computational biology work ... could lead to new ideas for curbing unwanted ... Nature Genetics , could also improve our ...
... and Women,s Hospital (BWH) and the Harvard-MIT Division ... way to deliver cancer drugs directly to tumors by ... pathway and deliver a higher concentration of medication to ... April 20, in an early online edition of the ...
... - Federal stimulus package provides needed economic boost to ... April 20 House Speaker Nancy Pelosi joined ... and Family Health Center to discuss the positive impact ... communities, which granted more than $10 million in federal ...
... few signs, imaging reveals patients at much greater risk ... "Silent" heart attacks occur more often than previously believed ... death, according to a Duke University Medical Center study. ... myocardial infarctions (UMIs), often go undetected because they don,t ...
Cached Medicine News:Health News:Renal Dietitian, Linda McCann, Receives 2009 Champion of Hope Award 2Health News:How cells change gears: New insights published in Nature Genetics 2Health News:How cells change gears: New insights published in Nature Genetics 3Health News:Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors 2Health News:Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors 3Health News:Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors 4Health News:Speaker Pelosi Visits Florida Health Center 2Health News:'Silent' Heart Attacks More Common Than Thought 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: